Zinc chelation therapy mitigates muscle fibrosis and improves functional outcomes in a murine model of crush syndrome
{{output}}
Background: The survivors from crush syndrome are often disabled due to the affected limbs, with excessive fibrosis changes at damaged muscle tissue. We previously reported that a zinc chelator (N,N,N',N'-tetrakis-(2-pyridylmet... ...
